Tag: Pfizer

Pfizer asks US to allow COVID shots for kids ages 5 to 11

Pfizer asked the U.S. government Thursday to allow use of its COVID-19 vaccine in children ages 5 to 11—and if regulators agree, shots could begin within a matter of weeks. Many parents and pediatricians are clamoring for protection for children younger than 12, today’s age cutoff for the vaccine made by Pfizer and its German

Pfizer and Moderna vaccines effective against new NYC variant​

The Pfizer-BioNTech and Moderna COVID-19 vaccines protect against serious illness and death from the coronavirus variant first identified in New York City, two new studies show. The B.1.526 variant was first detected in November and accounted for nearly half of cases diagnosed in the city as of April 13. City officials have said the variant

Pfizer CEO says a THIRD Covid vaccine may be needed

BREAKING NEWS: Pfizer CEO says a THIRD Covid vaccine dose will be needed as soon as six months after someone receives two shots – and then be vaccinated annually Pfizer CEO Albert Bourla said it is ‘likely’ people will need a booster shot of the COVID-19 vaccine The potential booster shot will be given within

Hong Kong halts use of Pfizer vaccine, cites defective lids

Hong Kong suspended use of the Pfizer vaccine Wednesday after its Chinese distributor informed the city that one batch had defective bottle lids. The city’s government said the suspension was immediate while the matter is investigated by distributor Fosun Pharma and BioNTech, the German company which created the vaccine with American pharmaceutical firm Pfizer. BioNTech

Single dose of Pfizer BioNTech vaccine reduces asymptomatic infections and potential for SARS-CoV-2 transmission

New data from Addenbrooke’s Hospital in Cambridge suggests that a single dose of the Pfizer BioNTech vaccine can reduce by four-fold the number of asymptomatic SARS-CoV-2 infections. This implies that the vaccine could significantly reduce the risk of transmission of the virus from people who are asymptomatic, as well as protecting others from getting ill.

Israeli study shows Pfizer vaccine 94 percent effective

Israel’s largest healthcare provider said Sunday a study of more than half a million fully vaccinated Israelis indicated the Pfizer/BioNTech jab gave 94 percent protection against COVID-19. Clalit Health Services said that in a groundbreaking project its researchers tested 600,000 subjects who had received the recommended two doses of the US-German Pfizer/BioNTech vaccine and the

FDA ‘rapidly working to finalize’ Pfizer coronavirus vaccine approval

Fox News Flash top headlines for December 11 Fox News Flash top headlines are here. Check out what’s clicking on Foxnews.com. The U.S. Food and Drug Administration (FDA) is working toward quickly finalizing and issuing emergency approval for Pfizer and BioNTech’s coronavirus vaccine candidate, according to top FDA officials. “Following yesterday’s positive advisory committee meeting outcome regarding the

US regulators post positive review of Pfizer vaccine data

Documents released by U.S. regulators Tuesday confirmed that Pfizer’s vaccine was strongly protective against COVID-19 and appeared safe—offering the world’s first detailed look at the evidence behind the shots. The positive review from the Food and Drug Administration sets the stage for a decision allowing the vaccine’s initial use within days. FDA regulators posted their